project id: TCGA-HNSC; case submitter id: TCGA-CN-A6V3; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.55; rna integrity number: 9.3; age at index: 61; days to birth: -22397; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22397; ajcc clinical m: M0; ajcc clinical n: N2b; ajcc clinical stage: Stage IVA; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 742.0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: Yes; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; years smoked: 40.0; is ffpe: false; composition: Not Reported; days to collection: 194; initial weight: 230.0; oct embedded: false; preservation method: Unknown; sample id: 285e2354-8efd-4951-87cf-0e188d11423e; sample submitter id: TCGA-CN-A6V3-01A; portion id: 45a7a359-6788-4648-b657-15a50b625895; portion submitter id: TCGA-CN-A6V3-01A-12; slide id: 15a4365b-52c2-4136-ab08-d745d04dc3c1; slide submitter id: TCGA-CN-A6V3-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0; section location: TOP;